"10.1371_journal.pone.0120020","plos one","2015-04-01T00:00:00Z","Ignacio Blanco; Karoline Kuchenbaecker; Daniel Cuadras; Xianshu Wang; Daniel Barrowdale; Gorka Ruiz de Garibay; Pablo Librado; Alejandro Sánchez-Gracia; Julio Rozas; Núria Bonifaci; Lesley McGuffog; Vernon S Pankratz; Abul Islam; Francesca Mateo; Antoni Berenguer; Anna Petit; Isabel Català; Joan Brunet; Lidia Feliubadaló; Eva Tornero; Javier Benítez; Ana Osorio; Teresa Ramón y Cajal; Heli Nevanlinna; Kristiina Aittomäki; Banu K Arun; Amanda E Toland; Beth Y Karlan; Christine Walsh; Jenny Lester; Mark H Greene; Phuong L Mai; Robert L Nussbaum; Irene L Andrulis; Susan M Domchek; Katherine L Nathanson; Timothy R Rebbeck; Rosa B Barkardottir; Anna Jakubowska; Jan Lubinski; Katarzyna Durda; Katarzyna Jaworska-Bieniek; Kathleen Claes; Tom Van Maerken; Orland Díez; Thomas V Hansen; Lars Jønson; Anne-Marie Gerdes; Bent Ejlertsen; Miguel de la Hoya; Trinidad Caldés; Alison M Dunning; Clare Oliver; Elena Fineberg; Margaret Cook; Susan Peock; Emma McCann; Alex Murray; Chris Jacobs; Gabriella Pichert; Fiona Lalloo; Carol Chu; Huw Dorkins; Joan Paterson; Kai-Ren Ong; Manuel R Teixeira; Teixeira; Frans B L Hogervorst; Annemarie H van der Hout; Caroline Seynaeve; Rob B van der Luijt; Marjolijn J L Ligtenberg; Peter Devilee; Juul T Wijnen; Matti A Rookus; Hanne E J Meijers-Heijboer; Marinus J Blok; Ans M W van den Ouweland; Cora M Aalfs; Gustavo C Rodriguez; Kelly-Anne A Phillips; Marion Piedmonte; Stacy R Nerenstone; Victoria L Bae-Jump; David M O'Malley; Elena S Ratner; Rita K Schmutzler; Barbara Wappenschmidt; Kerstin Rhiem; Christoph Engel; Alfons Meindl; Nina Ditsch; Norbert Arnold; Hansjoerg J Plendl; Dieter Niederacher; Christian Sutter; Shan Wang-Gohrke; Doris Steinemann; Sabine Preisler-Adams; Karin Kast; Raymonda Varon-Mateeva; Andrea Gehrig; Anders Bojesen; Inge Sokilde Pedersen; Lone Sunde; Uffe Birk Jensen; Mads Thomassen; Torben A Kruse; Lenka Foretova; Paolo Peterlongo; Loris Bernard; Bernard Peissel; Giulietta Scuvera; Siranoush Manoukian; Paolo Radice; Laura Ottini; Marco Montagna; Simona Agata; Christine Maugard; Jacques Simard; Penny Soucy; Andreas Berger; Anneliese Fink-Retter; Christian F Singer; Christine Rappaport; Daphne Geschwantler-Kaulich; Muy-Kheng Tea; Georg Pfeiler; BCFR; Esther M John; Alex Miron; Susan L Neuhausen; Mary Beth Terry; Wendy K Chung; Mary B Daly; David E Goldgar; Ramunas Janavicius; Cecilia M Dorfling; Elisabeth J van Rensburg; Florentia Fostira; Irene Konstantopoulou; Judy Garber; Andrew K Godwin; Edith Olah; Steven A Narod; Gad Rennert; Shani Shimon Paluch; Yael Laitman; Eitan Friedman; SWE-BRCA; Annelie Liljegren; Johanna Rantala; Marie Stenmark-Askmalm; Niklas Loman; Evgeny N Imyanitov; Ute Hamann; kConFab Investigators; Amanda B Spurdle; Sue Healey; Jeffrey N Weitzel; Josef Herzog; David Margileth; Chiara Gorrini; Manel Esteller; Antonio Gómez; Sergi Sayols; Enrique Vidal; Holger Heyn; GEMO; Dominique Stoppa-Lyonnet; Melanie Léoné; Laure Barjhoux; Marion Fassy-Colcombet; Antoine de Pauw; Christine Lasset; Sandra Fert Ferrer; Laurent Castera; Pascaline Berthet; François Cornelis; Yves-Jean Bignon; Francesca Damiola; Sylvie Mazoyer; Olga M Sinilnikova; Christopher A Maxwell; Joseph Vijai; Mark Robson; Noah Kauff; Marina J Corines; Danylko Villano; Julie Cunningham; Adam Lee; Noralane Lindor; Conxi Lázaro; Douglas F Easton; Kenneth Offit; Georgia Chenevix-Trench; Fergus J Couch; Antonis C Antoniou; Miguel Angel Pujana","Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), LHospitalet del Llobregat, Catalonia, Spain; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), LHospitalet del Llobregat, Catalonia, Spain; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), LHospitalet del Llobregat, Catalonia, Spain; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh; Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), LHospitalet del Llobregat, Catalonia, Spain; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain; Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America; Womens Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America; Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Center for Medical Genetics, Ghent University, Ghent, Belgium; Oncogenetics Group, Vall dHebron Institute of Oncology (VHIO), Vall dHebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain; All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom; All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom; Clinical Genetics, Guys and St. Thomas National Health Service (NHS) Foundation Trust, London, United Kingdom; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom; Yorkshire Regional Genetics Service, Leeds, United Kingdom; North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom; Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom; West Midlands Regional Genetics Service, Birmingham Womens Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom; Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands; Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands; Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands; Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America; Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America; Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America; Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany; Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany; Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany; Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany; Institute of Human Genetics, University of Münster, Münster, Germany; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark; Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy; Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy; Department of Molecular Medicine, Sapienza University, Rome, Italy; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy; Laboratoire de Diagnostic Génétique et Service dOnco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breast Cancer Family Registry (BCFR), Cancer Prevention Institute of California, Fremont, California, United States of America; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America; Department of Epidemiology, Columbia University, New York, New York, United States of America; Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America; Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa; Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary; Womens College Research Institute, University of Toronto, Toronto, Canada; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel; The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel; Swedish BRCA1 and BRCA2 Study (SWE-BRCA), Stockholm, Sweden; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; Department of Oncology, Lund University Hospital, Lund, Sweden; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Peter MacCallum Cancer Center, Melbourne, Australia; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America; St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America; The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, LHospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, LHospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain; Groupe Genetique et Cancer (GEMO), National Cancer Genetics Network, French Federation of Comprehensive Cancer Centers (UNICANCER), Paris, France; Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon–Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et dEpidémiologie Génétique, Centre Léon Bérard, Lyon, France; Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France; Centre François Baclesse, Caen, France; Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France; Département dOncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France; Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America; Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America","Conceived and designed the experiments: IB K. Kuchenbaecker KO GC-T FJC ACA MAP. Performed the experiments: K. Kuchenbaecker DC GRG NB ACA MAP FM. Analyzed the data: K. Kuchenbaecker DC XW DB GRG NB LM AI A. Berenguer A. Petit IC A. Gómez SS HH EV CG KO GC-T FJC ACA MAP. Contributed reagents/materials/analysis tools: IB K. Kuchenbaecker DC XW DB GRG PL AS-G JR NB LM VSP AI A. Bojesen A. Petit IC ME J. Brunet LF ET J. Benítez AO TRC HN KA BKA AET BYK CW J. Lester MHG PLM RLN ILA SMD KLN TRR RBB AJ J. Lubinski KD KJ-B KC TVM OD TVH LJ A-MG BE MH TC EMBRACE AMD CO EF M. Cook SP EM A. Murray CJ GP FL CC HD JP K-RO MRT HEBON FBLH AHH C. Sutter MGEMA MJLL PD JTW MAR HEJM-H MJBl AMWO CMA GCR K-AAP MP SRN VLB-J DMO ESR RKS BW KR CE A. Meindl ND NA HJP DN C. Singer SW-G DS SP-A K. Kast RV-M A. Gehrig A. Berger ISP LS UBJ MT TAK LF PP LB BP GS S. Mazoyer PR LO MM SA CM JS PS AB AF-R CFS CR DG-K M-KT GP BCFR EMJ A. Miron SLN MBT WKC MBD DEG RJ CMD EJR FF IK JG AKG SWE-BRCA AL JR MS-A NL ENI UH A. Gómez SS HH EV CG kConFab ABS SH JNW JH DM GEMO OMS DS-L ML S. Manoukian FD LB MF-C A. de Pauw CL SFF LC PB FC Y-JB EO SAN GR SSP YL EF CAM JV MR NK M. Corines DV JC AL NL CL DFE KO GC-T FJC ACA MAP MAD RBL. Wrote the paper: IB KK ACA MAP.","PP is an author of this study and is a member of the PLOS ONE Editorial Board; this does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2015","04","Ignacio Blanco","IB",199,TRUE,2,1,1,4,TRUE,FALSE,TRUE,173,"3;4;5;6;7;8;9;10;11;12;13;14;15;16;17;18;19;20;21;22;23;24;27;29;30;31;32;33;34;35;37;38;39;40;44;45;46;47;48;49;50;51;52;53;54;55;56;57;58;59;60;61;62;63;64;66;67;68;69;70;71;72;73;74;75;76;77;78;79;80;83;84;85;86;88;90;91;92;93;94;95;96;97;98;99;101;102;103;104;105;106;107;109;110;111;112;113;114;115;116;117;118;119;120;121;122;123;124;125;128;129;130;131;132;133;135;136;137;138;139;140;142;144;145;146;147;148;149;150;151;152;153;154;155;156;158;159;160;161;162;163;164;165;166;167;168;169;170;171;172;173;174;175;176;177;178;179;180;181;182;183;184;185;186;188;189;190;191;192;193;194;196;197",TRUE
